Virgin Herbert's Form 4 filing
Vir Biotechnology, Inc. (VIR) · filed Feb 22, 2022
- Accession no.
- 0001209191-22-011755
- Filed
- Feb 22, 2022
- Trade date
- Feb 17, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $73.2K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Virgin HerbertCIK 0001786378 | Officer (EVP, Research & CSO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2022 | Common Stock | SSaleDisposed | −2,293 | $31.93 | −$73,215.49 | 105,407 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.